Loading organizations...

§ Private Profile · 12 Farnsworth St. Boston, MA 02210
Developer of semiconductor Pixel systems for high-throughput phenotypic screening and real-time live cell analysis in drug discovery.
Founded in 2020 by Jeffrey Abbott and Vince Wu, CytoTronics is based in Boston, Massachusetts, developing semiconductor Pixel systems and cloud software for high-throughput phenotypic screening in cell biology. The startup provides hardware platforms that enable the real-time visualization and analysis of live cell functions, including viability, morphology, metabolism, electrophysiology, and electrochemistry. By assessing cellular heterogeneity with minimal starting material, this breakthrough technology supports drug discovery and biotechnology research across specialized fields like oncology, vascular biology, and personalized medicine. Operating with 21 to 50 employees, the company recently secured a $13,500,000 Series Seed 2 financing round in 2024 to accelerate the commercial market entry of its screening technology. This recent capital injection brings the firm's total funding raised to $22,800,000 across two rounds, supporting a leadership team that includes Director of Customer Success Joseph Maffei.
CytoTronics has raised $33.0M across 3 funding rounds.
CytoTronics has raised $33.0M in total across 3 funding rounds.
CytoTronics is a semiconductor‑enabled cell‑biology tools company that builds high‑throughput, label‑free platforms (Pixel™) to capture multi‑modal, live‑cell measurements at single‑cell resolution for drug discovery and cell‑biology research[3][4].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
CytoTronics has raised $33.0M across 3 funding rounds. Most recently, it raised $14.0M Seed in September 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2024 | $14M Seed | Lyfe Capital | Anzu Partners, BoxOne Ventures | Announced |
| Apr 1, 2022 | $9M Seed | Anzu Partners | 2XN, 8090 Industries, ARCH Venture Partners, AT ONE Ventures, BoxOne Ventures, Comal Ventures, Wave Financial, WestRiver Group, Elia Montanari, Jeffrey Wilke, Sahin Boydas, Thomas Tull | Announced |
| Dec 1, 2021 | $10M Seed | — | BoxOne Ventures, Mogrify, Sana Capital, Jonathan Milner | Announced |
CytoTronics has raised $33.0M in total across 3 funding rounds.
CytoTronics's investors include LYFE Capital, Anzu Partners, BoxOne Ventures, 2xN, 8090 Industries, ARCH Venture Partners, At One Ventures, Comal Ventures, Wave Financial, WestRiver Group, Elia Montanari, Jeffrey Wilke.